Disease Activity Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Psoriatic Arthritis
Authors:
- Natalia Palmou-FontanaNPNatalia Palmou-Fontana
- David Martínez-LopezDMDavid Martínez-Lopez
- Alfonso CorralesACAlfonso Corrales
- Javier Rueda-GotorJRJavier Rueda-Gotor
- Fernanda GenreFGFernanda Genre
- Susana ArmestoSusana Armesto
- Marcos A. González-LópezMGMarcos A. González-López
- Juan C. Quevedo-AbeledoJQJuan C. Quevedo-Abeledo
- Virginia Portilla-GonzálezVPVirginia Portilla-González
- Ricardo BlancoRBRicardo Blanco
- José L. HernandezJHJosé L. Hernandez
- Javier LlorcaJLJavier Llorca
- 15 November 2019
- journal article
- research article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 47 (9) , 1344-1353
Abstract
Objective.: Because the addition of carotid ultrasound (US) into composite cardiovascular (CV) risk scores has been found effective for identifying patients with inflammatory arthritis and high CV risk, we aimed to determine whether its use would facilitate the reclassification of patients with psoriatic arthritis (PsA) into the very high Systematic Coronary Risk Evaluation (SCORE) risk category and whether this might be related to disease features.Methods.: This was a cross-sectional study involving 206 patients who fulfilled ClASsification for Psoriatic ARthritis criteria for PsA, and 179 controls. We assessed lipid profile, SCORE, disease activity measurements, and the presence of carotid plaques and carotid intima-media thickness by ultrasonography. A multivariable regression analysis, adjusted for classic CV risk factors, was performed to evaluate whether the risk of reclassification could be explained by disease-related features and to assess the most parsimonious combination of risk reclassification predictors.Results.: Forty-seven percent of patients were reclassified into a very high SCORE risk category after carotid US compared to 26% of controls (p < 0.001). Patients included in the low SCORE risk category were those who were more commonly reclassified (30% vs 14%, p = 0.002). The Disease Activity Index for PsA (DAPSA) score was associated with reclassification (β 1.10, 95% CI 1.02–1.19; p = 0.019) after adjusting for age and traditional CV risk factors. A model containing SCORE plus age, statin use, and DAPSA score yielded the highest discriminatory accuracy compared to the SCORE-alone model (area under the receiver-operating characteristic curve 0.863, 95% CI 0.789–0.936 vs 0.716, 95% CI 0.668–0.764; p < 0.001).Conclusion.: Patients with PsA are more frequently reclassified into the very high SCORE risk category following carotid US assessment than controls. This was independently explained by the disease activity.Keywords
This publication has 33 references indexed in Scilit:
- The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis aloneAnnals of the Rheumatic Diseases, 2013
- Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled studyAmerican Journal of Hypertension, 2012
- Carotid Intima-Media Thickness in Psoriatic ArthritisArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- To Match or Not to Match in Epidemiological Studies—Same Outcome but Less PowerInternational Journal of Environmental Research and Public Health, 2010
- Subclinical carotid atherosclerosis in patients with psoriatic arthritisArthritis Care & Research, 2008
- High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factorsArthritis Care & Research, 2007
- Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyondStatistics in Medicine, 2007
- Mannheim Carotid Intima-Media Thickness Consensus (2004–2006)Cerebrovascular Diseases, 2006
- Classification criteria for psoriatic arthritis: Development of new criteria from a large international studyArthritis & Rheumatism, 2006
- Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global AssessmentJournal of the American Academy of Dermatology, 2004